🇺🇸 FDA
Patent

US 9598414

Substituted benzo[5,6]azepino[3,2,1-hi]pyrido[4,3-b]indoles and substituted benzo[6,7][1,4]oxazepino[2,3,4-hi]pyrido[4,3-b]indoles for treating CNS disorders

granted A61PA61P25/02A61P25/18

Quick answer

US patent 9598414 (Substituted benzo[5,6]azepino[3,2,1-hi]pyrido[4,3-b]indoles and substituted benzo[6,7][1,4]oxazepino[2,3,4-hi]pyrido[4,3-b]indoles for treating CNS disorders) held by DAYA DRUG DISCOVERIES, INC. expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DAYA DRUG DISCOVERIES, INC.
Grant date
Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P25/02, A61P25/18, A61P25/30